Key result
Pulsed field ablation offers superior safety in AF ablation by selectively targeting cardiac myocytes.
Why the study?
Pulsed field ablation selectively targets cardiac myocytes to minimize non-cardiac damage, but electrical field strength diminishes as distance increases.
Proximity monitoring needed to ensure adequate PFA energy delivery in AF; hypothesis-generating for clinical adoption pending prospective trials.
Pulsed field ablation (PFA) has emerged as a novel tool for catheter ablation of atrial fibrillation (AF) in recent years. This tool induces apoptosis through electroporation of cardiomyocytes by generating an electrical field. Due to different threshold for the electroporation among various cell/tissue types, PFA can selectively target cardiac myocytes, resulting in minimal damage to surrounding non-cardiac structures and thus offering a superior safety profile. However, electrical field strength diminishes as distance increases.
No takes yet. Share an insight, caveat, or question.
Kawaji et al. (2025) studied atrial fibrillation (AF). Pulsed field ablation (PFA) was evaluated. Pulsed field ablation selectively targets cardiac myocytes for atrial fibrillation ablation, offering a superior safety profile, though electrical field strength diminishes with distance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: